
Tori Strong
Examiner (ID: 17488, Phone: (571)272-6333 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629 |
| Total Applications | 381 |
| Issued Applications | 222 |
| Pending Applications | 0 |
| Abandoned Applications | 162 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15394013
[patent_doc_number] => 10537643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Chemoembolization composition comprising anti-angiogenic agents
[patent_app_type] => utility
[patent_app_number] => 15/637026
[patent_app_country] => US
[patent_app_date] => 2017-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 8578
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15637026
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/637026 | Chemoembolization composition comprising anti-angiogenic agents | Jun 28, 2017 | Issued |
Array
(
[id] => 14169273
[patent_doc_number] => 10258623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => Compositions and methods for reduction of amyloid-beta load
[patent_app_type] => utility
[patent_app_number] => 15/634593
[patent_app_country] => US
[patent_app_date] => 2017-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17387
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15634593
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/634593 | Compositions and methods for reduction of amyloid-beta load | Jun 26, 2017 | Issued |
Array
(
[id] => 15751159
[patent_doc_number] => 10617662
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-14
[patent_title] => Autophagy activation-induced compound for improving skin inflammation for aging
[patent_app_type] => utility
[patent_app_number] => 16/308689
[patent_app_country] => US
[patent_app_date] => 2017-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 11955
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308689
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308689 | Autophagy activation-induced compound for improving skin inflammation for aging | Jun 22, 2017 | Issued |
Array
(
[id] => 16799024
[patent_doc_number] => 10993939
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-04
[patent_title] => Compositions for treating or preventing vasomotor symptoms
[patent_app_type] => utility
[patent_app_number] => 16/308932
[patent_app_country] => US
[patent_app_date] => 2017-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 7535
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1047
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308932
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308932 | Compositions for treating or preventing vasomotor symptoms | Jun 11, 2017 | Issued |
Array
(
[id] => 11969801
[patent_doc_number] => 20170273956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA'
[patent_app_type] => utility
[patent_app_number] => 15/618736
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22570
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15618736
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/618736 | METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA | Jun 8, 2017 | Abandoned |
Array
(
[id] => 14833233
[patent_doc_number] => 20190275017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => TREATMENT OF PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/304914
[patent_app_country] => US
[patent_app_date] => 2017-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16304914
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/304914 | Treatment of Parkinson's disease | Jun 1, 2017 | Issued |
Array
(
[id] => 14892169
[patent_doc_number] => 20190289850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => FUNGICIDAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/306494
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16306494
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/306494 | Fungicidal compositions | May 25, 2017 | Issued |
Array
(
[id] => 16197320
[patent_doc_number] => 10722456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => Oral composition of celecoxib for treatment of pain
[patent_app_type] => utility
[patent_app_number] => 15/607216
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 29137
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15607216
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/607216 | Oral composition of celecoxib for treatment of pain | May 25, 2017 | Issued |
Array
(
[id] => 14926113
[patent_doc_number] => 20190298694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => Use Of Carbamate Compound For Preventing Or Treating Fibromyalgia Or Functional Syndrome Associated With Fibromyalgia
[patent_app_type] => utility
[patent_app_number] => 16/302858
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3788
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302858
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302858 | Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia | May 17, 2017 | Issued |
Array
(
[id] => 12057038
[patent_doc_number] => 20170333382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'METHOD OF TREATING HYPERGLYCEMIA'
[patent_app_type] => utility
[patent_app_number] => 15/597200
[patent_app_country] => US
[patent_app_date] => 2017-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9296
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15597200
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/597200 | Method of treating hyperglycemia | May 16, 2017 | Issued |
Array
(
[id] => 11941996
[patent_doc_number] => 20170246147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/597718
[patent_app_country] => US
[patent_app_date] => 2017-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16524
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15597718
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/597718 | COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER | May 16, 2017 | Abandoned |
Array
(
[id] => 13914883
[patent_doc_number] => 10201537
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-12
[patent_title] => Use of levocetirizine and montelukast in the treatment of autoimmune disorders
[patent_app_type] => utility
[patent_app_number] => 15/584795
[patent_app_country] => US
[patent_app_date] => 2017-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 12535
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15584795
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/584795 | Use of levocetirizine and montelukast in the treatment of autoimmune disorders | May 1, 2017 | Issued |
Array
(
[id] => 13942349
[patent_doc_number] => 10206919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-19
[patent_title] => Use of levocetirizine and montelukast in the treatment of vasculitis
[patent_app_type] => utility
[patent_app_number] => 15/584499
[patent_app_country] => US
[patent_app_date] => 2017-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11140
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15584499
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/584499 | Use of levocetirizine and montelukast in the treatment of vasculitis | May 1, 2017 | Issued |
| 15/491642 | Carbidopa and L-Dopa Prodrugs and Methods of Use | Apr 18, 2017 | |
Array
(
[id] => 11743909
[patent_doc_number] => 20170197982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'THIOPHENE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 15/468990
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18451
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15468990
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/468990 | Thiophene derivatives | Mar 23, 2017 | Issued |
Array
(
[id] => 11961992
[patent_doc_number] => 20170266145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'METHODS OF INDUCING METABOLIC MATURATION OF HUMAN PLURIPOTENT STEM CELLS-DERIVED HEPATOCYTES'
[patent_app_type] => utility
[patent_app_number] => 15/459139
[patent_app_country] => US
[patent_app_date] => 2017-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 28928
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15459139
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/459139 | Methods of inducing metabolic maturation of human pluripotent stem cells-- derived hepatocytes | Mar 14, 2017 | Issued |
Array
(
[id] => 14548743
[patent_doc_number] => 10342809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-09
[patent_title] => Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
[patent_app_type] => utility
[patent_app_number] => 15/459492
[patent_app_country] => US
[patent_app_date] => 2017-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20078
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15459492
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/459492 | Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same | Mar 14, 2017 | Issued |
Array
(
[id] => 11727911
[patent_doc_number] => 20170189352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'EPINEPHRINE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/455991
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 25258
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15455991
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/455991 | EPINEPHRINE FORMULATIONS | Mar 9, 2017 | Abandoned |
Array
(
[id] => 13248847
[patent_doc_number] => 10137095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-27
[patent_title] => Use of cannabinoids in the treatment of epilepsy
[patent_app_type] => utility
[patent_app_number] => 15/449535
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5146
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449535
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449535 | Use of cannabinoids in the treatment of epilepsy | Mar 2, 2017 | Issued |
Array
(
[id] => 11704442
[patent_doc_number] => 20170172941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'Use of Cannabinoids in the Treatment of Epilepsy'
[patent_app_type] => utility
[patent_app_number] => 15/449402
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5287
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449402
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449402 | Use of cannabinoids in the treatment of epilepsy | Mar 2, 2017 | Issued |